What have we learned from large drug treatment trials in COPD?
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference111 articles.
1. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium;Fletcher;Thorax,1984
2. Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 11 North American and Western European countries;Pride;Eur Respir J,1989
3. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study;Menezes;Lancet,2005
4. Epidemiology and costs of chronic obstructive pulmonary disease;Chapman;Eur Respir J,2006
5. Mortality in relation to smoking: 40 years' observations on male British doctors;Doll;BMJ,1994
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease: A post hoc analysis of the Tie-COPD study;Respiratory Medicine;2024-02
2. Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials;American Journal of Respiratory and Critical Care Medicine;2022-08-01
3. Modeling Clinical Trial Attrition Using Machine Intelligence: A driver analytics case study using 1,325 trials representing one million patients;2021-11-14
4. Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort;BMC Pulmonary Medicine;2020-05-29
5. COPD Phenotyping;Precision in Pulmonary, Critical Care, and Sleep Medicine;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3